DocMorris AG (CH:DOCM)
:DOCM
Switzerland Market

DocMorris (DOCM) Earnings Dates, Call Summary & Reports

Compare
0 Followers

Earnings Data

Report Date
Aug 19, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
-2.7
Last Year’s EPS
-3.22
Same Quarter Last Year
Moderate Buy
Based on 9 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 13, 2025
|
% Change Since: -19.22%
|
Next Earnings Date:Aug 19, 2025
Earnings Call Sentiment|Positive
The earnings call presented several positive developments, such as a significant increase in Rx customers, profitability in the non-Rx business, and strategic growth plans. However, challenges remain with lower than expected EBITDA and limited short-term guidance due to the capital raise. Overall, the sentiment is cautiously optimistic with a strong focus on future growth.
Company Guidance
In the recent conference call, DocMorris AG provided guidance for the upcoming fiscal year, highlighting several key metrics and strategic initiatives. The company reported a 7% increase in overall revenue for 2024, with a notable fivefold increase in new Rx customers since the introduction of CardLink. The non-Rx business reached profitability, contributing to an end-of-year cash balance of CHF95 million. For 2025, DocMorris aims to further expand Rx growth and plans to raise CHF200 million in capital to support this initiative and refinance a convertible bond due in 2026. Additionally, the Teleclinic segment doubled its revenues to CHF11 million, with a positive EBITDA of over CHF3 million, and is expected to continue its growth trajectory. The average order value for eRx customers reached €110, while over 85% of these customers utilized the app for prescriptions, resulting in a next-day home delivery rate exceeding 95%. The company also emphasized its commitment to sustainability, aligning its activities with the European Sustainability Reporting Standard. Despite a temporary lack of detailed guidance due to ongoing capital raising efforts, DocMorris expressed confidence in its strategic direction and market opportunities.
Significant Increase in Rx Customers
Since the introduction of CardLink in April 2024, there has been a fivefold increase in new Rx customers.
Profitability Achieved in Non-Rx Business
DocMorris AG reached profitability in its non-Rx business, attributed to strategic efforts and successful execution of a breakeven program.
Revenue Growth Across All Segments
Overall, there was a 7% increase in revenue with contributions from all business segments.
Teleclinic Revenue Doubled
Teleclinic achieved a milestone by doubling its revenues in 2024, demonstrating strong performance and attractive profitability metrics.
Strategic Capital Raise for Growth
DocMorris plans to raise about CHF200 million to support Rx growth and refinancing of the convertible bond 2026.
Sustainability Targets Met
DocMorris successfully reached its sustainability targets for 2024 and is aligned with the European Sustainability Reporting Standard.
---

DocMorris (CH:DOCM) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CH:DOCM Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 19, 20252025 (Q2)
-2.70 / -
-3.22
Mar 13, 20252024 (Q4)
-4.60 / -5.02
-5.11.57% (+0.08)
Aug 20, 20242024 (Q2)
-5.18 / -3.22
-5.00535.66% (+1.78)
Mar 21, 20242023 (Q4)
-4.39 / -5.10
-7.5932.81% (+2.49)
Aug 17, 20232023 (Q2)
-1.05 / -5.00
-8.2939.63% (+3.28)
Mar 23, 20232022 (Q4)
-7.05 / -7.59
-15.37350.63% (+7.78)
Aug 18, 20222022 (Q2)
-10.05 / -8.29
-8.03-3.24% (-0.26)
Mar 24, 20222021 (Q4)
-7.73 / -15.37
-8.703-76.64% (-6.67)
Aug 18, 20212021 (Q2)
-7.53 / -8.03
-5.87-36.80% (-2.16)
Mar 18, 20212020 (Q4)
- / -8.70
-4.061-114.31% (-4.64)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

CH:DOCM Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 13, 2025CHF21.12CHF15.06-28.69%
Aug 20, 2024CHF47.78CHF41.84-12.43%
Mar 21, 2024CHF79.80CHF79.60-0.25%
Aug 17, 2023CHF50.35CHF54.30+7.85%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does DocMorris AG (CH:DOCM) report earnings?
DocMorris AG (CH:DOCM) is schdueled to report earning on Aug 19, 2025, TBA Not Confirmed.
    What is DocMorris AG (CH:DOCM) earnings time?
    DocMorris AG (CH:DOCM) earnings time is at Aug 19, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of DocMorris AG stock?
          The P/E ratio of DocMorris is N/A.
            What is CH:DOCM EPS forecast?
            CH:DOCM EPS forecast for the fiscal quarter 2025 (Q2) is -2.7.
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis